Zacks Industry Outlook Highlights Bunge, West Fraser Timber, Hydrofarm and Arcadia Biosciences
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2024
0mins
Source: NASDAQ.COM
Industry Challenges and Opportunities: The Zacks Agriculture - Products industry faces challenges such as high input costs, labor shortages, and declining commodity prices, but is supported by increasing consumer demand for healthier food options and advancements in agricultural technologies like hydroponics and vertical farming.
Stock Performance and Key Players: Companies like Bunge, West Fraser Timber Co., Hydrofarm, and Arcadia Biosciences are well-positioned to benefit from market demands despite the industry's current underperformance compared to broader market indices, with a focus on innovation and cost management strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BG
Wall Street analysts forecast BG stock price to fall
6 Analyst Rating
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 121.740
Low
109.00
Averages
115.50
High
120.00
Current: 121.740
Low
109.00
Averages
115.50
High
120.00
About BG
Bunge Global SA is an agribusiness solutions company. The Company is engaged in the processing of oil seeds and the production and supply of specialty vegetable oils and fats. Its segments include Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. The Soybean Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybean and soybean related products, as well as biodiesel and fertilizer production and distribution. The Softseed Processing and Refining segment is a globally integrated business principally involved in the purchase, storage, transportation, processing, refining, marketing, and sale of soft seeds (canola/rapeseed, sunflower seed, and safflower seed) and soft seed related products, as well as biodiesel production and distribution.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bunge Global Q4 2025 Earnings Call Highlights
- Integration Benefits: CEO Gregory Heckman highlighted that the integration with Viterra has already realized $190 million in synergies ahead of schedule, optimizing origination, merchandising, and logistics, thereby enhancing the company's competitive position in a complex market environment.
- Financial Performance Review: In Q4 2025, reported earnings per share were $0.49, with adjusted EPS at $1.99, reflecting a decline from last year; however, all business segments showed year-over-year growth, demonstrating the company's resilience in the market.
- Outlook Projection: The company projects adjusted EPS for 2026 to be in the range of $7.50 to $8.00, based on the current market environment and forward curves, indicating confidence in future profitability.
- External Risk Factors: Management noted geopolitical tensions and uncertainties around biofuel policy could impact future performance; nevertheless, the company remains cautiously optimistic, emphasizing a commitment to disciplined capital allocation strategies.
See More
Bunge Reports Strong Quarter but Issues Softer Profit Outlook
- Quarterly Highlights: Bunge reported fourth-quarter adjusted earnings per share of $1.99, surpassing the analyst consensus of $1.81, with quarterly sales reaching $23.762 billion, exceeding the market expectation of $22.684 billion, indicating strong operational execution.
- Segment Performance: The Soybean Processing and Refining segment achieved quarterly net sales of $11.045 billion, significantly up from $8.374 billion a year ago, primarily driven by improved results in South America, particularly in Argentina and Brazil.
- Cash Flow Status: Despite a gross profit of $1.011 billion for the quarter, down from $1.081 billion a year prior, operating cash flow was $844 million, a sharp decline from $1.9 billion last year, mainly due to lower net income and changes in working capital.
- Future Outlook: Bunge anticipates adjusted earnings per share for 2026 to be between $7.50 and $8.00, below the analyst estimate of $8.71, although the company emphasizes that its expanded capabilities and diversified value chains will help it adapt to market fluctuations.
See More
Bunge Q4 Earnings Exceed Expectations
- Earnings Beat: Bunge reported a Q4 non-GAAP EPS of $1.99, surpassing expectations by $0.17, indicating robust profitability amid current economic conditions.
- Revenue Surge: The company achieved Q4 revenue of $23.76 billion, a 75.5% year-over-year increase, exceeding forecasts by $1.45 billion, showcasing strong performance and demand in the agricultural market.
- Cautious 2026 Outlook: Bunge anticipates adjusted EPS for 2026 to range between $7.50 and $8.00, below the consensus estimate of $8.94, reflecting uncertainty in future market conditions.
- Financial Guidance: The company expects an effective tax rate of 23% to 27%, net interest expense of $575 to $625 million, capital expenditures of $1.5 to $1.7 billion, and depreciation and amortization of approximately $975 million for 2026, indicating a cautious approach to future investments.
See More
Analysis and Outlook: A New Decline in Software Performance
Market Trends: The software market is experiencing a significant selloff, indicating a downturn in investor confidence.
Company Focus: Anthropic, a key player in the AI sector, is highlighted amidst the broader market challenges.
See More
Bunge to Announce Q4 Earnings on February 4th
- Earnings Announcement: Bunge is set to release its Q4 2023 earnings report on February 4th before market open, with consensus EPS estimate at $1.82, reflecting a 14.6% year-over-year decline, while revenue is expected to reach $22.31 billion, a 64.8% increase year-over-year.
- Historical Performance: Over the past two years, Bunge has exceeded EPS estimates 75% of the time and revenue estimates 38% of the time, indicating a degree of stability in its financial performance.
- Estimate Revision Trends: In the last three months, EPS estimates have seen one upward revision and five downward adjustments, while revenue estimates experienced two upward and two downward revisions, highlighting market divergence regarding the company's future outlook.
- Market Reaction: Morgan Stanley upgraded Bunge's rating, suggesting increased market confidence in company-specific drivers, while also noting that the impact of Viterra has been priced in by the market.
See More
Bunge Stock Falls 2.3% Following ADM's Pessimistic 2026 Profit Outlook
- Bunge Shares Decline: Bunge's shares fell by 2.3% following a disappointing earnings report.
- ADM's Profit Forecast: Archer-Daniels-Midland (ADM) has lowered its profit forecast for 2026, contributing to market concerns.
See More
Bunge Global Q4 2025 Earnings Call Highlights
- Integration Benefits: CEO Gregory Heckman highlighted that the integration with Viterra has already realized $190 million in synergies ahead of schedule, optimizing origination, merchandising, and logistics, thereby enhancing the company's competitive position in a complex market environment.
- Financial Performance Review: In Q4 2025, reported earnings per share were $0.49, with adjusted EPS at $1.99, reflecting a decline from last year; however, all business segments showed year-over-year growth, demonstrating the company's resilience in the market.
- Outlook Projection: The company projects adjusted EPS for 2026 to be in the range of $7.50 to $8.00, based on the current market environment and forward curves, indicating confidence in future profitability.
- External Risk Factors: Management noted geopolitical tensions and uncertainties around biofuel policy could impact future performance; nevertheless, the company remains cautiously optimistic, emphasizing a commitment to disciplined capital allocation strategies.
See More
Bunge Reports Strong Quarter but Issues Softer Profit Outlook
- Quarterly Highlights: Bunge reported fourth-quarter adjusted earnings per share of $1.99, surpassing the analyst consensus of $1.81, with quarterly sales reaching $23.762 billion, exceeding the market expectation of $22.684 billion, indicating strong operational execution.
- Segment Performance: The Soybean Processing and Refining segment achieved quarterly net sales of $11.045 billion, significantly up from $8.374 billion a year ago, primarily driven by improved results in South America, particularly in Argentina and Brazil.
- Cash Flow Status: Despite a gross profit of $1.011 billion for the quarter, down from $1.081 billion a year prior, operating cash flow was $844 million, a sharp decline from $1.9 billion last year, mainly due to lower net income and changes in working capital.
- Future Outlook: Bunge anticipates adjusted earnings per share for 2026 to be between $7.50 and $8.00, below the analyst estimate of $8.71, although the company emphasizes that its expanded capabilities and diversified value chains will help it adapt to market fluctuations.
See More
Bunge Q4 Earnings Exceed Expectations
- Earnings Beat: Bunge reported a Q4 non-GAAP EPS of $1.99, surpassing expectations by $0.17, indicating robust profitability amid current economic conditions.
- Revenue Surge: The company achieved Q4 revenue of $23.76 billion, a 75.5% year-over-year increase, exceeding forecasts by $1.45 billion, showcasing strong performance and demand in the agricultural market.
- Cautious 2026 Outlook: Bunge anticipates adjusted EPS for 2026 to range between $7.50 and $8.00, below the consensus estimate of $8.94, reflecting uncertainty in future market conditions.
- Financial Guidance: The company expects an effective tax rate of 23% to 27%, net interest expense of $575 to $625 million, capital expenditures of $1.5 to $1.7 billion, and depreciation and amortization of approximately $975 million for 2026, indicating a cautious approach to future investments.
See More
Analysis and Outlook: A New Decline in Software Performance
Market Trends: The software market is experiencing a significant selloff, indicating a downturn in investor confidence.
Company Focus: Anthropic, a key player in the AI sector, is highlighted amidst the broader market challenges.
See More
Bunge to Announce Q4 Earnings on February 4th
- Earnings Announcement: Bunge is set to release its Q4 2023 earnings report on February 4th before market open, with consensus EPS estimate at $1.82, reflecting a 14.6% year-over-year decline, while revenue is expected to reach $22.31 billion, a 64.8% increase year-over-year.
- Historical Performance: Over the past two years, Bunge has exceeded EPS estimates 75% of the time and revenue estimates 38% of the time, indicating a degree of stability in its financial performance.
- Estimate Revision Trends: In the last three months, EPS estimates have seen one upward revision and five downward adjustments, while revenue estimates experienced two upward and two downward revisions, highlighting market divergence regarding the company's future outlook.
- Market Reaction: Morgan Stanley upgraded Bunge's rating, suggesting increased market confidence in company-specific drivers, while also noting that the impact of Viterra has been priced in by the market.
See More
Bunge Stock Falls 2.3% Following ADM's Pessimistic 2026 Profit Outlook
- Bunge Shares Decline: Bunge's shares fell by 2.3% following a disappointing earnings report.
- ADM's Profit Forecast: Archer-Daniels-Midland (ADM) has lowered its profit forecast for 2026, contributing to market concerns.
See More
